Remove FDA Remove Labelling Remove Pharmaceutical Companies Remove Vaccines
article thumbnail

CMO Moves: Regulatory catalysts for drug manufacturing-April

Pharmaceutical Technology

This analysis covers late April to May and is based on a list of CMOs impacted by regulatory decisions by the US Food and Drug Administration (FDA), European Medicines Agency (EMA), and reimbursement authorities like the UK’s National Institute of Health and Care Excellence (NICE). Covid-19 vaccines stay in the spotlight.

article thumbnail

CMO Moves: Regulatory Catalysts for Drug Manufacturing-November

Pharmaceutical Technology

Crossing the approval hurdle for a new drug is a big milestone for pharmaceutical companies. Each month, Pharmaceutical Technology takes a look at recent decisions taken by regulatory and reimbursement agencies and identifies the key manufacturing players that can be impacted by them.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Remicade biosimilar options for affordable treatment

The Checkup by Singlecare

Understanding Remicade: Uses and mechanisms Remicade was the first tumor necrosis factor-alpha (TNF-alpha) inhibitor to be approved by the Food and Drug Administration (FDA). Since then, Remicade has also gained FDA indications for psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis.

FDA 52
article thumbnail

Top 20 Radiopharma Companies Based on Market Cap

PharmaShots

Market Cap: $8.46M Founded Year: 2004 Total Employees: ~4 Headquarters: Texas, United States Stock Exchange: OTCMKTS QSam Biosciences is a clinical-stage biotech company focused on developing and commercializing targeted therapeutic radiopharmaceutical products for treating cancer and related diseases.

FDA 56
article thumbnail

Twenty Women Leaders In Healthcare Industry

PharmaShots

Since its launch in 2016, Tivic Health has obtained three regulatory clearances for ClearUP, including FDA 510(k), FDA De Novo, and CE Mark, four patents, and numerous awards. With more than $50 billion in annual global revenue, Janssen has grown to be the second-largest innovative pharmaceutical company under her direction.

FDA 40
article thumbnail

Why are clinical trials struggling with diversity?

pharmaphorum

Within pharma and healthcare, where greater representation has been proven to lead to better health outcomes for all patients and the pharmaceutical companies developing medicines, change is also happening. Vaccines approved for public use require comprehensive RCTs to establish their safety and efficacy.

Packaging 141
article thumbnail

Insights+: An Analysis of the Growth of Biopharma Companies in the Last 20 Years (2003-2022)

PharmaShots

model is a holistic approach to incorporate the same strategy to life science and pharmaceutical companies. A globally fast-growing, and largest pharmaceutical company in the world was created through a merger between Pfizer and Pharmacia. Its top 8 products contributed more than $1B to the company’s net revenue.